BSX

Boston Scientific Corporation BSX

$44.03 -0.59 (-1.32%)

Pullback · -0.61σ Grade C

+ Compare Open in Sniper

Mkt cap $63.9B

P/E 18.4

Day $43.76 – $45.25

52wk $42.20 – $94.75

Avg vol —

Beta —

Div yld —

Next earnings —

Quick read

Plain English

Boston Scientific Corporation is a healthcare company listed in the US.

BSX last traded at $44.03, down 1.3% on the day; that's in the lower part of its 52-week range ($42.20–$94.75). Right now it's dipped below its recent average — a spot where watchers often look for signs the dip is stabilizing.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and after the recent dip, watch whether the price stops making lower lows before assuming the worst is over.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

Today's read

Grading desk →

below KC1 upper, -0.53 ATR from EMA21 — bearish engulfing

Long —

score 9 · tech 9 / 80 · support 0 / 20

above KC1 lower, -0.53 ATR from EMA21 · no notable pattern

· Stochastic bull cross
· Counter-trend long in strong downtrend

How this grade was earned

total 9 pts

Cycle position 6

Momentum 3

Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.

Short C

score 29 · tech 29 / 80 · support 0 / 20

below KC1 upper, -0.53 ATR from EMA21 · bearish engulfing

· Bearish engulfing — body fully covers prior green bar
· Aligned with strong downtrend (strong tailwind)

How this grade was earned

total 29 pts

Cycle position 6

Candle signal 13

Market fit 10

Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Under the hood

On the latest daily bar, momentum sits mid-range (RSI 42), the trend is strong (ADX 27), and volume is about normal (0.8×). On the business side, revenue is growing 12% year over year and the business keeps about 14 cents of every sales dollar as free cash.

Latest-bar indicator readings behind the grade — display-only, they don't move the letter.

Momentum · RSI

0–100 · <30 oversold

Trend strength · ADX

>25 = strong trend

Volume vs avg

0.77×

1× = average

Stretch from avg

-0.5 ATR

− below · + above

Zone touches

tests of this zone

Suggested hold

3–30

bars (≈ days)

Fundamentals at a glance

Company fundamentals for context — display-only, they don't move the grade.

Revenue growth

+11.6%

year over year

Free-cash-flow margin

14.0%

cash kept per $ of sales

Debt / equity

0.42

lower = less leveraged

P/E ratio

18.4

price ÷ yearly profit

Valuation & accounting

Valuation desk →

Our cash-flow model pegs fair value near $42.29 (fair range $38–$43); today's price sits 4% above that estimate. The model's verdict is “Fair” and accounting quality screens as Weak. Model estimates only — do your own due diligence.

Intrinsic (DCF)

$42.29

Fair-value range

$37.77 – $43.02

Margin of safety

-4%

Verdict

Fair

Accounting quality Weak

✓ Positive retained earnings
✓ Gross margin 69% (pricing power)

⚠ Debt exceeds cash
⚠ Quick ratio 0.81 (fragile)

Price implies ~12% growth (vs trailing rev yoy). Model estimate — do your own due diligence.

Key statistics

All statistics →

BSX is a $63.9 billion company, priced at 18× last year's earnings, and the stock is trading near the bottom of its 52-week range.

Mkt cap $63.9B

P/E ttm 18.4

Fwd P/E —

Beta —

Day range $43.76 – $45.25

52w range $42.20 – $94.75

Avg vol —

RSI(2) 51.1

ROE —

Net mgn —

FCF mgn 14.0%

Debt/Eq 0.42

Div yld —

Sector Healthcare

Industry Medical Devices

Next earn —

52-week range · today's price

$42.20$94.75